Quarterly report [Sections 13 or 15(d)]

Schedule of receivables with imputed interest (Details)

v3.25.1
Schedule of receivables with imputed interest (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Jun. 11, 2024
Receivables [Abstract]      
Face value $ 287,200 [1] $ 287,200 [1] $ 287,200
Impairment (250,208) (250,208) 250,208
Total 36,992 36,992  
Unamortized discount (36,992) (36,992) $ (36,992)
Net balance  
Long term portion  
[1] Coincident with the June 11, 2024 impairment, accounts receivable of $2,300 were reclassed and concurrently impaired. Prior to the full impairment, the Company reduced the face value of its investment in account receivable by an additional $100 per month for five receivable payment installments.